Filtros : "FCF004" Removidos: "Estudos Avançados" "República Tcheca" "Financiamento CAPES" "ENSINO CIÊNCIAS" Limpar

Filtros



Refine with date range


  • Source: Journal of Medicinal Chemistry. Unidade: FCF

    Subjects: MULHERES, QUÍMICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BLANCO, Maria Jesus et al. Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.1021/acsmedchemlett.4c00097. Acesso em: 20 ago. 2024. , 2024
    • APA

      Blanco, M. J., Bronson, J. J., DiMauro, E. F., Dzierba, C., Eggen, M. J., Garner, A. L., et al. (2024). Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1021/acsmedchemlett.4c00097
    • NLM

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
    • Vancouver

      Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
  • Source: Archives of Health. Unidade: FCF

    Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, AGENTES ANTIMICROBIANOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HERRERIAS, Bruna Viggiano et al. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, v. 5, n. 1, p. 17-26, 2024Tradução . . Disponível em: https://dx.doi.org/10.46919/archv5n1-003. Acesso em: 20 ago. 2024.
    • APA

      Herrerias, B. V., Fernandes, R. C., Gonzaga, R. V., Balista, P. A., Dario, M. F., & Sobreira, F. (2024). Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, 5( 1), 17-26. doi:10.46919/archv5n1-003
    • NLM

      Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.46919/archv5n1-003
    • Vancouver

      Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.46919/archv5n1-003
  • Source: Natural Product Research. Unidade: FCF

    Subjects: CAROTENOIDES, URUCUM

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TAKAMOTO, Rafael Teruiti de Oliveira et al. Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/14786419.2024.2350634. Acesso em: 20 ago. 2024.
    • APA

      Takamoto, R. T. de O., Hübner, A. A., Matuo, M. C. S., & Kikuchi, I. S. (2024). Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research. doi:10.1080/14786419.2024.2350634
    • NLM

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
    • Vancouver

      Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
  • Source: Value in Health Regional Issues. Unidade: FCF

    Subjects: MIELOMA MÚLTIPLO, REVISÃO SISTEMÁTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VISACRI, Marilia Berlofa et al. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, v. 43, p. 1-10 art. 100998, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vhri.2024.100998. Acesso em: 20 ago. 2024.
    • APA

      Visacri, M. B., Ribeiro, M. C., Komoda, D. S., Duarte, B. K. L., Corrêa, C. R. S., Maia, F. de O. M., & Alves, D. F. dos S. (2024). Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, 43, 1-10 art. 100998. doi:10.1016/j.vhri.2024.100998
    • NLM

      Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
    • Vancouver

      Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
  • Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: FCF, EEL

    Subjects: ENZIMAS, VENENOS DE ORIGEM ANIMAL

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CONTELLI, Ana P et al. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos. Acesso em: 20 ago. 2024.
    • APA

      Contelli, A. P., Ferraz, G. C., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., & Pedrozo, E. C. (2024). Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
    • NLM

      Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 ago. 20 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
    • Vancouver

      Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 ago. 20 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
  • Source: Nanomedicine. Unidades: FM, FCFRP, FCF

    Subjects: LEISHMANIA, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 20 ago. 2024.
    • APA

      Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
    • NLM

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
    • Vancouver

      Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
  • Source: Journal of Applied Electrochemistry. Unidade: FCF

    Subjects: ELETROQUÍMICA, VOLTAMETRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMEIDA, Lígia Scandoglieri de et al. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, v. 54, p. 41-52, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10800-023-01945-5. Acesso em: 20 ago. 2024.
    • APA

      Almeida, L. S. de, Chiavassa, L. D., Brito, C. de L., Gatti, F. de M., Trossini, G. H. G., & La Scalea, M. A. (2024). Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, 54, 41-52. doi:10.1007/s10800-023-01945-5
    • NLM

      Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1007/s10800-023-01945-5
    • Vancouver

      Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1007/s10800-023-01945-5
  • Source: Ageing Research Reviews. Unidade: FCF

    Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 20 ago. 2024.
    • APA

      Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
    • NLM

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
    • Vancouver

      Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
  • Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 20 ago. 2024.
    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
  • Source: Journal of Drug Delivery Science and Technology. Unidade: FCF

    Subjects: DEPRESSÃO, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 20 ago. 2024.
    • APA

      Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305
    • NLM

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
    • Vancouver

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
  • Unidade: FCF

    Subjects: IMUNOTERAPIA, NEOPLASIAS PULMONARES

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BHATT, Shvetank et al. Immunotherapy against lung cancer: emerging opportunities and challenges. . Singapore: Springer. . Acesso em: 20 ago. 2024. , 2024
    • APA

      Bhatt, S., Eri, R., Goh, B. H., Paudel, K. R., Pinto, T. de J. A., & Dua, K. (2024). Immunotherapy against lung cancer: emerging opportunities and challenges. Singapore: Springer.
    • NLM

      Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 ago. 20 ]
    • Vancouver

      Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 ago. 20 ]
  • Source: Cosmetics. Unidade: FCF

    Subjects: DESODORIZANTE, COSMÉTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MUSSI, Lilian et al. Deodorant efficacy of Xylityl sesquicaprylate vehiculated into roll-on and stick prototype formulations. Cosmetics, v. 11, p. 1-8 art. 88, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/ cosmetics11030088. Acesso em: 20 ago. 2024.
    • APA

      Mussi, L., Baby, A. R., Nogueira, C., Camargo Júnior, F. B. de, & Magalhães, W. V. (2024). Deodorant efficacy of Xylityl sesquicaprylate vehiculated into roll-on and stick prototype formulations. Cosmetics, 11, 1-8 art. 88. doi:10.3390/cosmetics11030088
    • NLM

      Mussi L, Baby AR, Nogueira C, Camargo Júnior FB de, Magalhães WV. Deodorant efficacy of Xylityl sesquicaprylate vehiculated into roll-on and stick prototype formulations [Internet]. Cosmetics. 2024 ; 11 1-8 art. 88.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.3390/ cosmetics11030088
    • Vancouver

      Mussi L, Baby AR, Nogueira C, Camargo Júnior FB de, Magalhães WV. Deodorant efficacy of Xylityl sesquicaprylate vehiculated into roll-on and stick prototype formulations [Internet]. Cosmetics. 2024 ; 11 1-8 art. 88.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.3390/ cosmetics11030088
  • Source: Skin Pharmacology and Physiology. Unidades: FCF, EE

    Subjects: RECÉM-NASCIDO, PELE, HIGIENE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RAMOS, Mily Constanza Moreno et al. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial. Skin Pharmacology and Physiology, v. 36, n. 6, p. 267–277, 2024Tradução . . Disponível em: https://dx.doi.org/10.1159/000536066. Acesso em: 20 ago. 2024.
    • APA

      Ramos, M. C. M., Velasco, M. V. R., Bueno, M., & Veríssimo, M. D. L. Ó. R. (2024). Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial. Skin Pharmacology and Physiology, 36( 6), 267–277. doi:10.1159/000536066
    • NLM

      Ramos MCM, Velasco MVR, Bueno M, Veríssimo MDLÓR. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial [Internet]. Skin Pharmacology and Physiology. 2024 ; 36( 6): 267–277.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1159/000536066
    • Vancouver

      Ramos MCM, Velasco MVR, Bueno M, Veríssimo MDLÓR. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial [Internet]. Skin Pharmacology and Physiology. 2024 ; 36( 6): 267–277.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1159/000536066
  • Source: Journal of Biomolecular Structure and Dynamics. Unidade: FCF

    Subjects: MACRÓFAGOS, SISTEMA IMUNE, LISOSSOMOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NASCIMENTO, Lucas Adriano do e FERREIRA, Glaucio Monteiro e FERREIRA, Elizabeth Igne. Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states. Journal of Biomolecular Structure and Dynamics, v. 42, n. 12, p. 6448–6454, 2024Tradução . . Disponível em: https://doi.org/10.1080/07391102.2023.2235603. Acesso em: 20 ago. 2024.
    • APA

      Nascimento, L. A. do, Ferreira, G. M., & Ferreira, E. I. (2024). Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states. Journal of Biomolecular Structure and Dynamics, 42( 12), 6448–6454. doi:10.1080/07391102.2023.2235603
    • NLM

      Nascimento LA do, Ferreira GM, Ferreira EI. Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states [Internet]. Journal of Biomolecular Structure and Dynamics. 2024 ; 42( 12): 6448–6454.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1080/07391102.2023.2235603
    • Vancouver

      Nascimento LA do, Ferreira GM, Ferreira EI. Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states [Internet]. Journal of Biomolecular Structure and Dynamics. 2024 ; 42( 12): 6448–6454.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1080/07391102.2023.2235603
  • Source: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF

    Subjects: NEOPLASIAS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 20 ago. 2024.
    • APA

      Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
    • NLM

      Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
    • Vancouver

      Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
  • Source: Journal of AOAC International. Unidade: FCF

    Assunto: MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOURENÇO, Felipe Rebello e SILVA, Ricardo Jorge Neves Bettencourt da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products. Journal of AOAC International, 2024Tradução . . Disponível em: https://dx.doi.org/10.1093/jaoacint/qsae044. Acesso em: 20 ago. 2024.
    • APA

      Lourenço, F. R., & Silva, R. J. N. B. da. (2024). Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products. Journal of AOAC International. doi:10.1093/jaoacint/qsae044
    • NLM

      Lourenço FR, Silva RJNB da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products [Internet]. Journal of AOAC International. 2024 ;[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1093/jaoacint/qsae044
    • Vancouver

      Lourenço FR, Silva RJNB da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products [Internet]. Journal of AOAC International. 2024 ;[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1093/jaoacint/qsae044
  • Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: MEDIÇÃO DE RISCO, MÉTODO DE MONTE CARLO, QUALIDADE DOS MEDICAMENTOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AMARAL, Gustavo Kenji Toko Purcino do e LOURENÇO, Felipe Rebello. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences, v. 60, p. 1-9, 2024Tradução . . Disponível em: https://dx.doi.org/10.1590/s2175-97902024e23565. Acesso em: 20 ago. 2024.
    • APA

      Amaral, G. K. T. P. do, & Lourenço, F. R. (2024). Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences, 60, 1-9. doi:10.1590/s2175-97902024e23565
    • NLM

      Amaral GKTP do, Lourenço FR. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2024 ; 60 1-9.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1590/s2175-97902024e23565
    • Vancouver

      Amaral GKTP do, Lourenço FR. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2024 ; 60 1-9.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1590/s2175-97902024e23565
  • Source: Fronters Chemistry. Unidade: FCF

    Subjects: POLIFENÓIS, COSMÉTICOS, ANTI-INFLAMATÓRIOS, ANTIOXIDANTES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RUSCINC, Nadia et al. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Fronters Chemistry, v. 12, p. 1-11 art. 1400881, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fchem.2024.1400881. Acesso em: 20 ago. 2024.
    • APA

      Ruscinc, N., Serafim, R. A. M., Almeida, C., Rosado, C., & Baby, A. R. (2024). Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Fronters Chemistry, 12, 1-11 art. 1400881. doi:10.3389/fchem.2024.1400881
    • NLM

      Ruscinc N, Serafim RAM, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry [Internet]. Fronters Chemistry. 2024 ; 12 1-11 art. 1400881.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.3389/fchem.2024.1400881.
    • Vancouver

      Ruscinc N, Serafim RAM, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry [Internet]. Fronters Chemistry. 2024 ; 12 1-11 art. 1400881.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.3389/fchem.2024.1400881.
  • Source: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF

    Subjects: ESPECTROFOTOMETRIA, BIOEQUIVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOBADILLA, Vanessa Saldaña et al. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, v. 12, n. 3, p. 539-547, 2024Tradução . . Disponível em: https://dx.doi.org/10.56499/jppres23.1846_12.3.539. Acesso em: 20 ago. 2024.
    • APA

      Bobadilla, V. S., Villanueva, C. P. B., Gasco, F. J. G., Chauca, E. P., Aquiño, O. E. C., Rodriguez, A. E. M., et al. (2024). Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, 12( 3), 539-547. doi:10.56499/jppres23.1846_12.3.539
    • NLM

      Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539
    • Vancouver

      Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539
  • Source: Exploratory Research in Clinical and Social Pharmacy. Unidade: FCF

    Subjects: SERVIÇOS FARMACÊUTICOS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Julie Faria Ferreira de et al. Key performance indicators for pharmaceutical services: a systematic review. Exploratory Research in Clinical and Social Pharmacy, v. 14, p. 1-8, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.rcsop.2024.100441. Acesso em: 20 ago. 2024.
    • APA

      Souza, J. F. F. de, Fernandes, B. D., Rotta, I., Visacri, M. B., & Lima, T. de M. (2024). Key performance indicators for pharmaceutical services: a systematic review. Exploratory Research in Clinical and Social Pharmacy, 14, 1-8. doi:10.1016/j.rcsop.2024.100441
    • NLM

      Souza JFF de, Fernandes BD, Rotta I, Visacri MB, Lima T de M. Key performance indicators for pharmaceutical services: a systematic review [Internet]. Exploratory Research in Clinical and Social Pharmacy. 2024 ; 14 1-8.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.rcsop.2024.100441
    • Vancouver

      Souza JFF de, Fernandes BD, Rotta I, Visacri MB, Lima T de M. Key performance indicators for pharmaceutical services: a systematic review [Internet]. Exploratory Research in Clinical and Social Pharmacy. 2024 ; 14 1-8.[citado 2024 ago. 20 ] Available from: https://dx.doi.org/10.1016/j.rcsop.2024.100441

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024